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At sites of inflammation or tissue injury, proteolytic enzymes are released by
neutrophils, platelets, damaged tissue, and activation products of the comple-
ment, coagulation, and fibrinolytic pathways . These proteinases must ultimately
be inactivated to prevent incidental destruction of surrounding uninvolved tissue
and to ensure the orderly initiation of tissue repair. It has recently been recog-
nized that protease inhibitors may be produced by macrophages as well as by
liver and, therein, provide both local and remote mechanisms for proteinase
inactivation at sites of tissue injury . Human monocytes and macrophages synthe-
size and secrete a, proteinase inhibitor (PI)' (1, 2), Cl inhibitor (3, 4), plasmino-
gen-activator inhibitor (5), a2 macroglobulin (6), and collagenase inhibitor (7).
a, PI is a 55-kD glycoprotein that constitutes the principle serum inhibitor of
neutrophil elastase . It is encoded by an -.,10-kb gene on human chromosome 14
(8, 9) . It is consideredamember ofasupergene family that includes antithrombin
III, ovalbumin (10), angiotensinogen (11), 02 antiplasmin (12), a, antichymotryp-
sin (13), protein C inhibitor (14) and C 1 inhibitor (15, 16). These genes bear
30-40% primary structural homology and have a number of residues around
the active inhibitory region that are highly conserved. Each one of these serpins
is characterized by a specificity for inhibition of individual serine proteinases,
although each is also able to inhibit other serine proteinases less effectively
(reviewed in reference 17) .
There is considerable polymorphic variation of a, PI . One variant allele, PiZ,
is associated with a severe reduction in serum concentrations of functionally
active a, PI . This deficiency is often associated with premature development of
pulmonary emphysema, and 15-20% of PiZZ individuals are affected by pro-
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gressive liver disease (reviewed in references 18, 19). A number of studies have
directly demonstrated (2, 20-22) a selective defect in secretion of a, PI in PiZZ
individuals, probably affecting the transport of a, PI from the endoplasmic
reticulum to the Golgi apparatus. The defect is expressed in liver cells and cells
of mononuclear phagocyte lineage (2).
Plasma concentrations of a, PI increase three- to fourfold during acute
inflammation or tissue injury (23). A number of other human hepatic acute-
phase reactants have now been shown (24-25) to be regulated in human hepa-
toma cells (HepG2 and Hep3B) by the monokines IL-1 and cachectin/TNF. The
rate of synthesis of a, PI in HepG2 and Hep3B cells is not affected by IL-1,
TNF (25), or by supernatants of LPS-stimulated peripheral blood mononuclear
cells (26). Conversely, significant increases in expression of a, PI have been
demonstrated in human monocytes and macrophages. A product of mitogen-
stimulated T4+ lymphocytes (27) mediates a 2.0-2.5-fold increase and neutrophil
elastase (28) mediates a 3.5-8-fold increase in steady-state levels of a, PI mRNA
and rate of synthesis of a, PI in cultured extrahepatic mononuclear phagocytes .
In this study we examined the effect of inflammatory activation by a bacterial
product, LPS, on expression of the a, PI gene in macrophages from normal and
homozygous PiZZ a, PI-deficient individuals.
Materials and Methods
DME and DME lacking methionine were purchased from Gibco Laboratories, Grand
Island, NY. HBSS and Medium 199 (M199) were purchased from Microbiological Asso-
ciates, Walkersville, MD. FCS, L-glutamine, and penicillin-streptomycin were from Flow
Laboratories, Inc., McLean, VA. [s5S]Methionine (specific radioactivity ^-1,000 Ci/mmol)
and [s2P]deoxycytidine triphosphate (specific radioactivity ^-3,000 Ci/mmol) were ob-
tained from New England Nuclear, Boston, MA, and ["C]methylated protein standards
were from Amersham Corp., Arlington Heights, IL. Other reagents included IgG-Sorb
from Enzyme Center, Cambridge, MA; cesium chloride from Bethesda Research Labo-
ratories, Gaithersburg, MD; guanidine isothiocyanate from Fluka AG, Buchs, Switzerland;
and sodium-N-laurylsarcosinate from ICN Pharmaceuticals, Inc., Irvine, CA. Goat anti-
human factor B, goat anti-human C3, goat anti-human Cl inhibitor were purchased
from Atlantic Antibodies, Scarborough, ME; rabbit anti-human a, PI and rabbit anti-
human a2 macroglobulin were from Dako Corp., Santa Barbara, CA; and sheep anti-
human C2 came from Miles Laboratories Inc., Naperville, IL. Goat anti-human neutro-
phil elastase was provided by James Travis, University of Georgia, Athens, GA. LPS
preparations extracted from two different strains of Escherichia coli (serotypes 0111 :B4
and 026:116), each extracted by two different procedures (TCA precipitation and Westphal
phenolic extraction) were purchased from Sigma Chemical Co. E. coli 0113 LPS was also
purchased from Associates of Cape Cod, Inc., Woods Hole, MA. mAb to the lipid A
moiety of LPS (8A1 [29]) was kindly provided by Dr. Warren C. Bogard, Centocor
Malvern, PA.
Cell Culture.
￿
Confluent monolayers of human peripheral blood monocytes from 24
normal PiMM and 3 symptomatic PiZZ individuals (as defined by IEF, serum levels, and
family studies) were established by adherence of dextran-purified leukocytes on siliconized
glass as previously described (30). Bronchoalveolar macrophages were obtained from
sterile saline bronchial lavage. After centrifugation and washing, cells were allowed to
adhere to siliconized glass cover slips (31). HepG2 and Hep3B cells were maintained in
culture as previously described (32). Murine L cells transfected with the cloned human a,
PI gene (TfAT2) were maintained in selective medium. The TfAT2 cell line was derived
by cotransfection of murine Ltk- cells with HSV thymidine kinase DNA and a genomic
DNA clone bearing the entire human a, PI gene and 5-6 kb of 5' and 3' flanking regionsBARBEY-MOREL ET AL.
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(AT73 [33], kindly provided by Professor R. Cortese, Heidelberg, Federal Republic of
Germany) by calcium phosphate precipitation (34). Synthesis and secretion of a, PI was
demonstrated in this cell line, but not in the parent untransfected Ltk- cell line (28).
LPS contamination was detected and quantified by limulus amebocyte lysate assay
(Associates of Cape Cod, Inc.). The LPS concentration of the cell culture before the
addition of exogenous LPS was <10 pg/ml, when detectable.
Biosynthetic Labeling.
￿
Confluent monolayers were rinsed and incubated at 37°C in the
presence of methionine-free medium containing ["S]methionine, 500 UCi/ml (pulse
period). To determine the rate of synthesis of a, PI or control secretory proteins, cells
were subjected to a short pulse interval (30 min), and radiolabeled proteins were detected
in the cell lysate alone. To determine the rate of secretion of a, PI, cells were subjected
to a pulse period of 30 min, rinsed, and incubated in serum-free medium containing an
excess of unlabeled methionine (chase period). Radiolabeled a, PI was detected in cell
culture fluid and cell lysates at specified intervals of the chase period. To determine the
accumulation of a, PI in the cell culture fluid, cellswere subjected to a long pulse interval
(3 h) and radiolabeled a, PI was identified in cell culture fluid alone. Methods for
solubilization of cells and clarification of cell lysates after labeling have been described
(1). Total protein synthesis was estimated by TCA precipitation of aliquots of cell lysates
and culture fluid (35).
Immunoprecipitation and SDS-PAGE.
￿
Aliquots of cell lysate or medium were incubated
overnight at 4°C in 1% Triton X-100/1 .0% SDS/0.5% deoxycholic acid, with excess
antibody . Immune complexes were precipitated with excess formalin-fixed staphylococci-
bearing protein A, washed, released by boiling in sample buffer, and applied to 9.0%
SDS-PAGE under reducing conditions as described by Laemmli (36). ' C-methylated
molecular size markers (200,000; 92,500; 68,000; 46,000; 30,000; and 17,000 mol wt)
were included on all gels. After electrophoresis, gels were stained in Coomassie Brilliant
Blue, destained, impregnated with 2,5-diphenyloxazole (ENgHANCE, New England Nu-
clear), and dried for fluorography on XAR x-ray film (Eastman Kodak Co., Rochester,
NY). LKB Instruments, Inc. Houston, TX laser densitometer 2222 ultrascan XL was used
for scanning of fluorograms.
Detection ofRNA by RNA Blot Analysis.
￿
Total cellular RNA was isolated from adherent
monolayers of monocytes and macrophages by guanidine isothiocyanate extraction and
ethanol precipitation (37). RNA was quantified by absorbance at 260 nm and solubilized
for agarose-formaldehyde gel electrophoresis and transfer to nitrocellulose filters (38).
Filters were then hybridizedwith 3'P-labeled cDNA specific for human a, PI (39), human
factor B (40), human C3 (41), and human a2 macroglobulin (kindly provided by Dr. B. F.
Tack, Scripps Clinic and Research Institute, La Jolla, CA).
Results
LPS Mediates an Increase in the Rate of Synthesis of a, PI in Human Blood
Monocytes and Bronchoalveolar Macrophages.
￿
Monolayers of peripheral blood
monocytes after 24 h in culture were incubated for an additional 24 h in control
serum-free medium or medium supplemented with LPS (Fig. 1, left). LPS
mediates a concentration-dependent increase in the rate of synthesis of a, PI.
The effect of LPS is evident at concentrations of LPS as low as 1 ng/ml. At the
highest concentration tested (1 ttg/ml), the rate of a, PI synthesis increased 8 .7-
fold. LPS from three different strains of E. coli, each prepared by two different
extraction procedures, have the same effect on synthesis of a, PI (data not
shown). Accumulation of a, PI in the intracellular contents and cell culture fluid
after a long interval of pulse radiolabeling increased 5.0- and 4 .6-fold, respec-
tively (Fig. 1, right), suggesting that LPS does not have a significant effect on the
rate ofposttranslational processing or secretion of newly synthesized a, PI. Pulse-
chase experiments, described below, also demonstrate that LPS affects the rate1044 ENDOTOXIN REGULATES a, PROTEINASE INHIBITOR EXPRESSION
FIGURE 1 .
￿
Effect of LPS on synthesis and secretion of a, PI in peripheral blood monocytes .
After 24 h in culture, monocytes were incubated for 24 h in serum-free medium alone (0) or
supplemented with LPS in the specified concentrations. Cells were then subjected to pulse
radiolabeling for 30 min (left) or 3 h (right) . a, PI was detected in cell lysates (left; right, IC) or
culture fluid (EC). Molecular mass markers are indicated in the right margin .
of synthesis of a, PI but not the rate of its secretion . The effect of LPS results
in an increase of similar magnitude in the accumulation of native 55-kD a, PI
and a 75-kD form of a, PI in complex with an endogenous monocyte serine
elastase (1, 42, 43) (Fig . 1, right) . Activation of monocytes by LPS, therefore,
results in an increase in functional activity of a, PI, as defined by the capacity to
form a stable complex with serine elastase, as well as an increase in rate of
synthesis of a, PI (Fig. 1, left) . Moreover, there is an increase in functional
activity of a, PI despite the potential for inactivation by oxygen radicals (44),
cysteine proteases (45), or metalloenzymes (46), which may also be released by
LPS-activated monocytes . Conversely, the rate of synthesis of elastase in mono-
cytes is not affected by LPS (Fig. 2) .
The effect of LPS is time dependent (Fig. 3) . Rate of synthesis of a, PI
increases within 8 h. The effect ofLPS is still evident after 24 h .
LPS has a similar effect on a, PI expression in blood monocytes and tissue
macrophages . The rate of synthesis of a, PI increases 4.8-7.2-fold in monocytes
incubated with LPS after 1, 5, and 10 d in culture (Fig. 4), despite the specific
decrease in expression of a, PI that ordinarily accompanies in vitro maturation
of monocytes (1, 27). The rate of synthesis of a, PI increases 4.5-fold in
bronchoalveolar macrophages incubated with LPS after 1 d in culture (Fig . 5) .
LPS also regulates the expression of other serine protease inhibitors in mon-
ocytes and macrophages . The rate of synthesis of Cl inhibitor increases 5-fold
in LPS-treated alveolar macrophages, while that of a2 macroglobulin decreases
3.7-fold (Fig . 5) . These effects are specific in that other products of the macro-
phage increase to a different extent, including complement components C3 (3-
fold) and factor B (4.2-fold), or are not affected, as shown by C2 (Fig . 5) .BARBEY-MOREL ET AL .
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FIGURE 2 .
￿
Effect of LPS on synthesis of neutro-
philic elastase in peripheral bloodmonocytes . Sam-
ples from the experiment shown in Fig . 1, left,
were immunoprecipitated with goat anti-human
neutrophil elastase after immunoprecipitation with
anti-human a, PI . M r markers indicated in the
right margin .
FIGURE 3 .
￿
The effect of LPS on synthesis of
a, PI is time dependent. After 24 h in culture
monocytes were incubated for 24 h in serum-
free medium alone (0) or supplemented with
LPS, 100 ng/ml, for the specified time inter-
vals . Cells were then subjected to pulse radio-
labeling for 30 min and a, PI was detected in
cell lysates . M r markers are indicated in the
right margin .
FIGURE 4.
￿
LPS regulates the synthesis of a,
PI in humanmonocytes duringin vitro matura-
tion. Monolayers of monocytes after 1, 5, and
10 d in culture were incubated for 24 h in
serum-free medium alone (-) or medium sup-
plemented with LPS, 100 ng/ml . Cells were
then subjected to pulse radiolabeling for 60
min and a, PI was detected in cell lysates.
Results are expressed as relative densitometric
units .
The effect of LPS on expression of a, PI in mononuclear phagocytes was
neutralized by preincubation with mAb to E. coli lipid A (Fig . 6) . LPS had no
effect on the rate of synthesis of a, PI in human hepatoma cells HepG2 or
Hep3B or in a stable transfected cell line, mouse fibroblast L cells transfected
with the human a, PI gene (data not shown) .
The Effect ofLPS on Expression of a1P1 in Mononuclear Phagocytes Involves Both1046 ENDOTOXIN REGULATES a, PROTEINASE INHIBITOR EXPRESSION
FIGURE 5. Specificity of the response of
macrophages to activation by LPS . After 24
h in culture, confluent monolayers of mac-
rophages were incubated for 24h in serum-
free medium (0) or medium supplemented
with LPS in the specified concentrations .
Cells were then subjected to pulse radiola-
beling . a, PI, other serine protease inhibi-
tors, and serine proteases were detected in
cell lysates by sequential . immunoprecipita-
tion . Molecular mass markers are indicated
in the right margin.
FIGURE 6 .
￿
Specificity of the effect of LPSon expression of a,
PI in blood monocytes . After 24 h in culture monocytes were
incubated for 8 h in serum-free medium alone, medium supple-
mented with LPS 1 ng/ml, medium supplemented with LPS 1
ng/ml, and mAb to lipid A (8A1 [29]),15 ng/ml or 75 ng/ml,
or medium supplemented with monoclonal antibody to lipid A,
75 ng/ml alone. Cellswere then subjected to pulse radiolabeling
for 60 min and a, PI was detected in cell lysates . M, markers
are indicated in the right margin .
FIGURE 7 . Effect of LPS on
steady-state levels of a, PI mRNA
in monocytes and macrophages .
After24h in culture, monolayers
of blood monocytes (Mono) or
bronchoalveolar macrophages
(Mac) were incubated for 12 h in
serum-free medium alone (-) or
supplemented with LPS, 100
ng/ml (+) . RNA was then sub-
jected to RNAblot analysis using
radiolabeled a, PI cDNA as
probe . Similar amounts of ethid-
ium bromide-stained 18S and
28S were visualized in each lane .
18S and 28S ribosomal RNA is
indicated in the right margin .
Pretranslational and Translational Mechanisms.
￿
Total cellular RNA was isolated
from confluent monolayers of control or LPS-treated monocytes or macrophages
and subjected to RNA blot analysis . In contrast to its effect on the rate of
synthesis of a, PI, the effect of LPS on steady-state levels of a, PI mRNA is
variable . In some experiments, accumulation of a, PI mRNA increases less than
2-fold in the presence of LPS (Fig. 7). In other experiments, steady-state levels
of a, PI increase 2.5-fold (Fig. 8). The difference in the magnitude of the LPS
effect on steady-state levels of a, PI mRNA (1 .5-2.5-fold increase) and rate ofBARBEY-MOREL ET AL .
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FIGURE 8 .
￿
Time-dependent changes in a, PI mRNA in LPS-activated monocytes and mac-
rophages . After 24 h in culture, monolayers of monocytes were incubated for 24 h in serum-
free medium alone (0) or for the specified time intervals in serum-free medium supplemented
with LPS, 100 ng/ml . RNA was then subjected toRNA blot analysis with radiolabeled a, PI,
a y macroglobulin, or factor B cDNA as probe. Similar amounts ofethidium bromide-stained
18S and 28S RNA were visualized in each lane . 18S and 28S ribosomal RNA is indicated in
the right margin .
synthesis of a, PI (4.5-8.7-fold increase) is not a result oftime-dependent changes
(Fig . 8) or dose-dependent changes (data not shown) . LPS did mediate a 4-6-
fold increase in steady-state levels of factor B mRNA and a decrease in a2
macroglobulin mRNA levels in the same experiments (Fig . 8) . These results
suggest that the effect of LPS on expression of a, PI involves both pretransla-
tional and translational mechanisms, but predominantly results from an increase
in the efficiency of translation of a, PI mRNA . Although less likely, it is not
possible to completely exclude the possibility that LPS decreases the rate of
degradation of a, Pl .
The Effect ofLPS on Expression of a, PI in Monocytes From Deficient Individuals
Exaggerates the Intrinsic Cellular Defect. The cellular defect in homozygous PiZZ
a, PI deficiency, a selective decrease in the rate of secretion of a, PI, is expressed
in monocytes from PiZZ individuals (2) . Therefore, it is possible to examine the
effect of enhanced translation of a, Pl, as mediated by LPS, on a cell in which
there is a defect in posttranslational processing/transport . Monocytes from PiMM
and PiZZ individuals were separately incubated in control medium or medium
supplemented with LPS and then subjected to pulse-chase radiolabeling (Fig . 9) .
The rate of synthesis of a, PI increases to a similar extent in PiMM and PiZZ
monocytes (compare IC time 0 left top with right top and IC time 0 left bottom
to IC time 0 right bottom) . Although a, PI is already disappearing from the
intracellular contents and appearing in the extracellular fluid by 30 min of the
chase period in PiMM monocytes, it accumulates in intracellular contents over
the entire chase period in PiZZ monocytes . These results indicate that upregu-
lation of the expression of a, PI by a pretranslational mechanism, as mediated
by a product of T4+ lymphocytes (27) or by serine elastase (28), or by a
translational mechanism, as mediated by LPS, results in a greater intracellular
accumulation of a, PI in PiZZ monocytes .1048 ENDOTOXIN REGULATES a, PROTEINASE INHIBITOR EXPRESSION
FIGURE 9 .
￿
Effect of LPS on the kinetics of secretion ofa, PI inPiMM and PiZZ monocytes.
After 24 h in culture monocytes from PiMM (top panels) and PiZZ individuals (bottom panels)
were incubated for 24 h in medium alone (control) or medium supplemented with LPS 100
ng/ml (LPS) . Monolayers were then subjected to pulse-chase radiolabeling . M, markers are
indicated .
Discussion
These experiments demonstrate tissue-specific, predominantly translational
regulation of the expression of a, PI in human mononuclear phagocytes by LPS .
The increase in a, PI expression in blood monocytes and bronchoalveolar
macrophages is part of a program of specific changes in expression of serine
protease inhibitors that accompany activation by LPS. There is an increase in
expression ofC i inhibitor and a decrease in expression of a2 macroglobulin .
Changes in expression of a, PI and other serine protease inhibitorsaccompany
many other specific changes in gene expression in macrophagesduring activation
by LPS . Production of tumoricidal activity (47), superoxide anions (44), mon-
okines (48, 49), prostaglandin metabolites (50), neutral proteases (51), proteases
of the complement (40, 52, 53), coagulation (54), and fibrinolytic pathways (55),
and proto-oncogenes (56) in human mononuclear phagocytes are regulated
during LPS activation . Recent studies (49, 57, 58) of endotoxin-resistant states
have suggested that regulation ofmacrophage gene expression by LPS involvesBARBEY-MOREL ET AL.
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distinct transcriptional and translational control mechanisms. In cord blood
monocytes, endotoxin mediates an increase in steady-state levels ofC3 andfactor
B mRNA (58), but there is no accompanying change in the synthesis orsecretion
of C3 or factor B (57). In macrophages of the endotoxin-resistant C3H/HeJ
mouse or in dexamethasone-treated macrophages of the endotoxin-sensitive
C3H/HeN mouse there areincreases incachectin/TNF mRNA levels in response
to endotoxin but no changesin the accumulation ofcachectin in the extracellular
fluid (49). A conserved sequence of 33 nucleotides composed entirely of A and
T residues has been noted in the 3'-untranslated region of genes encoding
several cytokines that are regulated by LPS, including cachectin/TNF, lympho-.
toxin, IL-1, granulocyte/macrophage colony-stimulating factor, and the IFNs
(59). This sequence is thought to be a recognition signal for degradation of
specific mRNAs (60) and to be involved in posttranscriptional stabilization of
these mRNAs in response to LPS (61). This sequence is not found in the 3'-
untranslated region ofthe human a, PI gene (62). Moreover, there is a variable
and less significant increase in steady-statelevels ofa, PI mRNA levels inresponse
to endotoxin,indicating thata predominantly translationalmechanismis involved
in this particular regulatory effect of endotoxin.
The results ofthese experiments also extend our understanding of the factors
that affect the net biological activity of macrophage-derived a, PI in tissues.
During homeostasis, a, PI activity may be affected by the state ofdifferentiation
of the mononuclear phagocyte, by the local microenvironment, by interaction
with serine elastase (1), by interaction with metallo elastases (46), as well as with
cysteine proteases (45). During inflammation or tissue injury, expression of a,
PI in cells of mononuclear phagocyte lineage may be directly regulated by
products of activated lymphocytes (27), by proteolytic enzymes such as elastase
(28), by products ofbacteria such as LPS, and probably by products ofoxidative
metabolism (63). In contrast, expression of a, PI in the only well-characterized
human liver cell culture systems, human hepatoma cell lines HepG2 and Hep3B,
is regulated to only a limited extent. The rate of synthesis of a, PI may be
increased by twofold in HepG2 cells incubated with crude supernatants of
alloantigen-stimulated T4+ clones (27, 28), but is not affected by IL-1, TNF (25),
IFN-y or crude supernatants of LPS-stimulated peripheral blood mononuclear
cells (26). Regulation of other hepatic acute-phase genes in these cell lines is
mediated by each ofthese cytokines or cytokine preparations (25, 26, 64). These
observations raise the possibility that in humans, expression ofa, PI by hepato-
cytes is largely constitutive while that ofmacrophages is regulated.
Expression ofa, PI in macrophages from PiZZ individuals is also regulated by
LPS. In this instance, an increase in the efficiency of translation ofa, PI mRNA
may further compromise the deficient host. Rate of synthesis of a, PI increases
but rate ofsecretion is not affected. The result is greater intracellular accumu-
lation of the inhibitor. An increase in steady-state levels of a, PI mRNA as
mediated by crude lymphokine supernatants (27) or by serine elastase (28) also
results in greater intracellular accumulation of a, PI in deficient macrophages.
Nevertheless, the effect of LPS in the deficient individual may be especially
profound since it also directly downregulates theexpression ofa2 macroglobulm,1050 ENDOTOXIN REGULATES a, PROTEINASE INHIBITOR EXPRESSION
another elastase inhibitor expressed in macrophages at local tissue sites of
inflammation or tissue injury.
Summary
a, Proteinase inhibitor (PI) is the principle inhibitor of neutrophil elastase, an
enzyme that degrades many components of the extracellular matrix . Expression
and regulation of a, PI, therefore, affects the delicate balance of elastase and
antielastase, which is critical to turnover of connective tissue during homeostasis,
tissue injury, and repair. In this study we show that expression of a, PI in human
monocytes and macrophages is regulated during activation by LPS . LPS mediates
a concentration- and time-dependent increase in the rate of synthesis of a, PI in
mononuclear phagocytes. There is a 4.5-8.7-fold increase in functionally active
inhibitor delivered to the cell culture fluid of monocytes. The effect of LPS is
specific in that it is neutralized by an mAb to the lipid A moiety. The increase
in expression of a, PI mediated by LPS occurs in the context of other specific
changes in the expression of serine proteinase inhibitor genes in mononuclear
phagocytes. There is an increase in the rate of synthesis of C 1 inhibitor and a
decrease in synthesis of a2 macroglobulin. Regulation of a, PI by LPS is
distinctive in that it is largely determined by a change in the efficiency of
translation of a, PI mRNA. LPS has no effect on the rate of posttranslational
processing and/or secretion of a, PI and, therein, causes greater intracellular
accumulation of a, PI in mononuclear phagocytes from individuals with homo-
zygous PiZZ a, PI deficiency.
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